Introduction
Over the past few decades, there has been an enormous effort devoted to the synthesis and biochemical and biological evaluation of analogs of natural nucleosides and nucleotides. This 20 has largely been due to their usefulness as tools in investigations aimed at a thorough understanding of metabolic processes. Such analogues exhibit their biological properties either via inhibition of enzymes of nucleoside/nucleotide metabolism pathway or in the triphosphorylated form, where they can become incorporated 25 into DNA or RNA via the action of polymerases or transcriptases. One of the most successful classes of nucleotide analogs are those that posses the enzymatically and chemically stable phosphonate moiety 1 as a replacement for the phosphate group. The advantage of this modification is to improve stability by preventing 30 hydrolysis of the phosphate ester bond.
Systematic investigation of the structurally diverse nucleoside phosphonic acids has led to the development of potent antiviral drugs. Their chemistry is based on both the acyclic phosphonate nucleotides 1 2, 3 and cyclic counterparts 2 and 3 ( Fig. 1 ).
7 9 ring-containing compounds have been reported. However, among these only analogues 6a-e exerted significant inhibition of HIV reverse transcriptase comparable to AZT as well maintaining a low level of cytotoxicity. Pyrrolidine nucleosides 8 and 9 10 served as starting point for the synthesis of pyrrolidine 5 phosphonate analogs of nucleotides 10a -12, recently described by our group 11 . Phosphonate derivative 13 has been found to be a potent inhibitor of thymidine phosphorylase from spontaneous SD-rat lymphoma cells exhibiting IC 50 of 11 nM 12 and guanine derivative 14 exhibited nanomolar activity against human purine 10 nucleoside phosphorylase. 13 Herein, we present the synthesis and biological evaluation of phosphonomethoxyethyl derivatives of nucleobases 15a-e and 16a-b (Figure 2 ) that are conformationally locked via a pyrrolidine ring. The conformational lock may, in principle, 15 increase the entropy contribution to the binding energy of ligand to its biological target. Herein we attempted to compare inhibition properties of PMEG and PMEHx with their conformationally locked counterparts 15b-c and 16b-c towards oxopurineribosyltransferases. 
Scheme 1 Synthesis of precursors 19 and 23
Monodimethoxytrityl derivative 17 was reacted with diisopropyl 35 tosyloxymethanphosphonate to afford phosphonate 18 that was treated with 1.5% TFA in DCM to yield the first intermediate 19.
Compound 19 was mesylated and treated with sodium azide giving azido derivative 21. This reaction was accompanied by removal of one isopropyl ester group decreasing the yield of 21. 40 Thus, a different route to azido derivative 21 was explored. Starting monodimethoxytrityl derivative 17 was first converted to the azido derivative 22 that subsequently reacted with diisopropyl tosyloxymethanephosphonate. The obtained azido derivative 21 was finally converted to the amino derivative 23 by catalytic 45 hydrogenation over a palladium catalyst. The chloropurine intermediate 25 was prepared by the Mitsunobu reaction of hydroxyderivative 19 with 6-chloropurine (24) (Scheme 2). Adenine derivative 15a was prepared from 25 by aminolysis with conc. aqueous ammonia and dioxane followed by stirring with 50 20% TFA in DCM (removal of Boc protecting group) and finally by bromotrimethylsilane treatment (to remove isopropyl esters). The hypoxanthine derivative 15b was prepared from the same intermediate 25 by bromotrimethylsilane treatment followed by heating with aq. 3M HCl.
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Scheme 2 Synthesis of adenine and hypoxanthine derivatives 15a and 15b and heated with Dowex 50 in H + for 5 h. The treatment with Dowex accomplished the cyclisation of uracyl moiety, removal of 5 Boc protecting group and, surprisingly, removal of both isopropyl ester groups thus, leading to the final uracil derivative 15d. The thymine derivative 15e was prepared by the same procedure except reagent 28 was replaced by reagent 29 15 (Scheme 4).
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Scheme 4 Synthesis of uracil and thymine derivatives 15d and 15e
The uracil derivative 16a with a trans configuration was prepared using the same synthetic procedure as for derivative 15d (Scheme 5). The starting azidoderivative 30 was prepared according to our previously published procedure 13 . Hypoxanthine derivative 16b 15 and guanine derivative 16c were prepared using nucleobase assembly approach adopted from 16 (employing 4,6-dichloro-5-formamidopyrimidine (32) and 2-amino-4,6-dichloro-5-formamidopyrimidine (33) respectively) followed by bromotrimethylsilane promoted isopropyl ester groups removal. 20 The reaction of amino derivative 31 with 32 and 33 did not lead to purine ring closure so additional treatment with diethoxymethyl acetate in DMF at elevated temperature was required. It appears that the nucleobase assembly on primary amino group is preferred procedure for introduction of thymine or 25 uracil but for purine bases the Mitsunobu alkylation is the method of choice.
NMR conformational analysis
The final compounds 15a-e and 16a-c were fully characterized by 30 1 H, 13 Since the original acyclic phosphonate moiety in 15a-e and 16a-b is conformationally restricted by the five-membered pyrrolidine ring we were interested in conformation preferences of such pyrrolidine derivatives. Taking into account that molecules contain both acidic (phosphonic acid) and basic 50 (pyrrolidine component) moieties, we first examined at which pD deuteration/dedeuteration transitions take place ( Figure 3 ) Therefore, D 2 O solutions of 15a and 16c were titrated with diluted solutions of DCl in D 2 O or NaOD in D 2 O and 1 H, 13 C and 31 P NMR spectra were acquired (see Supporting Information). 2' and C-5' 13 C chemical shift changes. At pD ~ 4, dedeuteration of adenine nitrogen N-1was observed by the changes in 13 C chemical shift of C-2 and C-6. We have also found that deuteration/dedeuteration of other derivatives 15b-e and 16a-b follows the same trends resulting in dedeuteration of positively 65 charged pyrrolidine nitrogen at pD ~ 10.
The protonation/deprotonation or deuteration/dedeuteration of the pyrrolidine nitrogen can influence the conformation of the five-membered pyrrolidine ring (Figure 4) . 4 Pyrrolidine pseudorotation pathway (P = 0° to 360°) of PME derivatives 15a-e and 16a-c. The sign B stands for a nucleobase and R means a phosphonomethyl moiety.
The particular conformation is described by two pseudorotation 5 parameters: by the phase angle (P) and by the maximum puckering amplitude ( max ). 17 The phase angle is a periodic variable indicating which ring atoms are situated outside the ring plane and can reach 0°-360°. The maximum puckering amplitude describes the degree of distortion of the five-membered ring out 10 of the plane and its value is usually in the range of 35°-45°. Therefore, we examined conformation preferences of the pyrrolidine ring in cis-adenine derivative (15a) and trans-guanine derivative (16c) at low (<2.0) and high (>12.0) pD values. The conformation analysis based on the concept of pseudorotation 17 15 was performed using 3 J(H,H) spin-spin couplings of pyrrolidine ring protons within the Matlab Pseudorotation GUI program 18 and the methodology developed for the conformational analysis of pyrrolidine nucleotide analogues we have published previously. 19 In trans-derivative 16c, we observed only negligible 20 changes in 3 J(H,H) of pyrrolidine protons upon pD change indicating little or no change in conformation of the pyrrolidine ring. This assumption was later confirmed by the conformation analysis of 16c ( Figure 5 ) that revealed the existence of very similar conformations at both high and low pD. The conformation analysis of cis-derivative 15a at pD < 10 30 revealed an exclusive existence of one conformer (P = 26°) constrained by strong hydrogen bonding between the phosphonate moiety and the deuterated positively charged pyrrolidine nitrogen ( Figure 7 ). This hydrogen bonding is weakened as a consequence of dedeuteration at pD >10, which 35 results in an equilibrium of two conformers (P 1 = 26° (75%), P 2 = 253° (25%)) in D 2 O solution. Similar behavior was also observed for hypoxanthine and guanine derivatives 15b and 15c, respectively. 10 Streptococcus agalactiae, Candida albicans, and Candida krusei) activities but no significant effects were observed. Compounds 15a-e and 16a-b did not exhibit any inhibitory activity against human mitochondrial (mdN) and cytosolic (cdN) 5'(3')-deoxynucleotidases. 20 Compounds 15a and 15e were tested 15 in a HCV replicon assay and did not exhibit any activity at concentration below 50 µM.
Inhibition of human HGPRT and
PfHGXPRT by pyrollidine derivatives of PME derivatives of the acyclic nucleoside 20 
phosphonates
The K i values of four compounds were determined for human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and P.falciparum (Pf) hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) -a potential drug target 25 for treatment of malaria (Table 1 ). There are two chemical differences between these compounds: (i) the purine base is either guanine or hypoxanthine; and (ii) there are two isomers. One has the S configuration at the carbon atom of the five membered ring and the second has the R configuration. Structural analysis Docking studies were undertaken to try to understand how the pyrrolidine derivatives bind in the active site. 22 The crystal structures of human HGPRT in complex with 9-2-[-45 2(phosphonoethoxy)ethyl]guanine (PEEG) and 9-2-[-2(phosphonoethoxy)ethyl]hypoxanthine (PEEHx) (PDB: 3GGC and 3GGJ, respectively) were used as the model template. 21 The PEE compounds contain an extra carbon atom in the linker connecting the N 9 atom of the purine ring with the phosphorous 50 atom of the phosphonate group compared with 15b, 15c, 16b and 16c. However, they are similar in that they both contain an oxygen atom two atoms distal to the N 9 . The acyclic nucleoside phosphonates (PEEG and PEEHx) bind to two key regions in the actives site of human HGPRT: the purine binding site and the 5'-55 phosphate binding pocket (D137-T141). 21 To validate this approach, we first docked PEEG and PEEHx into the protein devoid of ligand. The results showed that all the highest scoring docking poses correlated with the position observed in the crystal structure. The rmsd for all atoms in the ligands was < 0.2Å 60 ( Figure 8a and 8b). The docked structures of 15b and 16b are compared in Figure 8c and those of 15c and 16c are compared in Figure 8d . This data shows that the phosphonate group in all four compounds is found in the 5-phosphate binding pocket, but it can 10 have two different orientations depending on the isomer. Thus, the chemical structure of the two isomers appears to be responsible for the location of the phosphonate group. Therefore, the nature of the base itself does not affect the location of the phosphonate group (cf. 15b with 15c and 16b with 16c). The 15 differences in affinity for each isomer with either guanine or Hx as the base only relates to the binding of the base itself as human HGPRT has a higher affinity for guanine over hypoxanthine but PfHGXPRT binds hypoxanthine better than guanine. 23 For the weaker inhibitors of human HGPRT (15b and 15c), the 20 phosphonate group does not reach as far into 5-phosphate binding pocket as it does in 16b and 16c. This location of the phosphonate group in the active site could be one of the contributing factors for the differences in the K i values between the human and Pf enzymes for the two isomers. In comparison, 25 PfHGXPRT favours the S-isomers of the pyrrolidine nucleoside phosphonates over their R-isomer counterparts. The docking studies suggest that the "open" structure of these pyrrolidine derivatives is preferred to the "locked" structure when these compounds bind in the active site of the 6-oxopurine 30 phosphoribosyltransferases.
Conclusions
Eight PME derivatives of nucleobases with a locked conformation via a pyrrolidine ring have been synthesized. Pyrimidine derivatives were prepared in good yields via 35 nucleobase construction on primary amine. In the case of purine bases, Mitsunobu coupling with hydroxy derivative appeared to be better approach than construction of the nucleobase on primary amino group. NMR conformation analysis revealed that the conformation of pyrrolidine ring in cis-series 15 is pH 40 dependent. It was found that protonation of pyrrolidine ring at pH < 10 is responsible for the constraining of the conformation and the exclusive existence of one conformer. Derivatives bearing hypoxanthine and guanine nucleobases were tested as inhibitors of the human and Plasmodium falciparum 6-oxopurine 45 phosphoribosyltransferases. The most potent compound 15b has a K i of 0.6 µM for Pf HGXPRT with a selectivity in favour of the Pf enzyme over its human counterpart of approx. 120-fold (Sisomer). However, when the purine base is the same but the isomer is different (R-isomer), this selectivity changes in favour 50 of the human enzyme (14-fold in favour of the human enzyme). Docking studies suggests that R-isomer is favoured for the human HGPRT because the phosphonate group reaches further into the 5-phosphate binding pocket. This allows the phosphoryl oxygens to form more hydrogen bonds with the amino acid side chain or 55 main chain atoms in the flexible loop surrounding this group. These findings will help us in designing better and more selective inhibitors of parasite HGXPRT.
Experimental
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Unless stated otherwise, all used solvents were anhydrous. Final products were lyophilized from water, and dried over phosphorus pentoxide at 50-70 °C and 13 Pa. TLC was performed on silica gel pre-coated aluminium plates Silica gel/TLC-cards, UV 254 (Fluka), and compounds were detected by UV light (254 nm), by 65 heating (detection of dimethoxytrityl group; orange color), by spraying with 1% solution of ninhydrin to visualize amines, and by spraying with 1% solution of 4-(4-nitrobenzyl)pyridine in ethanol followed by heating and treating with gaseous ammonia (blue color of mono-and diesters of phosphonic acid).
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Preparative column chromatography was carried out on silica gel (40-60m; Fluka) neutralized with triethylamine (1 ml/100 g), and elution was performed at the flow rate of 40 ml/min. The following solvent systems were used for TLC and preparative chromatography:
toluene-ethyl acetate 1:1 (T); This intermediate (0.69 g, 1.384 mmol) was without further characterisation dissolved in 20% TFA in DCM (20 ml). The reaction mixture was stirred at rt overnight. The reaction mixture 15 was diluted with chloroform (50 ml) and extracted with water (2x50 ml). The aqueous phase was applied to column of Dowex 50 in H + form. Dowex was washed with water (200 ml) and eluted with 3% aq. ammonia. The yellowish solution was evaporated. The residue was co-evaporated with ethanol (1x20 20 ml) and acetonitrile (2x20 ml) and dissolved in DMF (15 ml). Bromotrimethylsilane (1 ml, 7 mmol) was added under argon atmosphere and the reaction mixture was stirred at rt for two days. The reaction mixture was concentrated in vacuo. 2M aq. TEAB (5 ml) and ethanol (10 ml) were added. The solution was by column chromatography on silica gel using linear gradient of ethanol in chloroform in the form of yellowish foam. Dowex 50 in H + form (10 g) was added to the solution of the intermediate in dioxane (15 ml) . The suspension was stirred at 85 °C for 5 h. The reaction mixture was filtered, the resin was washed with ethanol 25 (50 ml) and eluted with 3% aq. ammonia (100 ml). The filtrate was concentrated and the desired product was obtained by preparative reverse phase HPLC with a 54% overall yield (0.2 g, 0.64 mmol) after conversion to sodium salt by passing through a column of Dowex 50 in Na + form and lyophilisation from water dioxane (25 ml). The suspension was stirred at 85 °C for 5 h. The reaction mixture was filtered, the resin was washed with ethanol (50 ml) and eluted with 3% aq. ammonia (100 ml). The filtrate was concentrated and the desired product was obtained by preparative reverse phase HPLC in 32% overall yield (175.6 mg, 65 0,54 mmol) after conversion to sodium salt by passing through a column of Dowex 50 in Na + form and lyophilisation from water in the form of white amorphous solid. 1 .52 ml, 3 .05 mmol) in nBuOH (10 ml) was stirred at 110 °C overnight. The reaction mixture was concentrated in vacuo, dissolved in DMF (5 ml), diethoxymethyl acetate (3 ml) was added, and the mixture was stirred at 120 °C overnight. Chloropurine intermediate was obtained by chromatography on 5 silica gell using linear gradient of etanol in chloroform and was used in the next step without further characterisation (except of LCMS). The intermediate (0.31 g, 0.6 mmol) was stirred in 1.5 M aq. HCl (50 ml) at 75 °C overnight, applied on column of Dowex 50 in H+ form (100 ml), washed with 50% aq. etanol (150 ml) 10 and eluted with 3% NH 3 in 50% aq. etanol (300 ml). Obtained yellow solution was evaporated and purified using preparative HPLC on reversed phase. Obtained hypoxanthine diisopropyl ester (80 mg, 0.2 mmol) was co-evaporated with MeCN (3x10 ml), dissolved in the same solvent, and Me 3 SiBr (0.13 ml, 1 NaHCO 3 (2x400 ml), 10% aq citric acid (2x400 ml) and water (2x400 ml). The organic phase was dried over sodium sulfate, filtered and concentrated in vacuo. The residue was dissolved in DMF (1 L). Sodium azide (26 g, 400 mmol) was added and the reaction mixture was stirred at 110 °C overnight. The reaction 105 mixture was concentrated in vacuo. Ethyl acetate (500 ml) was added to the residue. The slurry was filtered and concentrated in vacuo. 1.5% TFA in DCM (600 ml), was added and the mixture was stirred until complete removal of the DMTr group (followed by TLC in 50% EtOAc/Toluene and 10% EtOH in chloroform) -110 cca 2h. Solid NaHCO 3 (40 g) and MeOH (100 ml) was added in portions. The mixture was vigorously stirred until the pH was neutral (~30 min). The suspension was filtered and the filtrate was concentrated in vacuo. coordinates. Prior to docking simulations the enzyme was protonated using the GOLD default settings. The active site centre was defined by the coordinates of the phosphorus atom of PEEG or PEEHx when bound to human HGPRT. The search radius for all calculations was 15 Å. For each ligand twenty 5 independent docking searches were performed. The GoldScore fitness function (default settings) was used to rank the poses. This algorithm takes into account H-bonding energy, van der Waals energy and ligand torsion strain.
